Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections
Status:
Terminated
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This is a Phase 4, randomized, open-label, multicenter, comparative study designed to further
evaluate the pharmacokinetics of intravenous (i.v.) daptomycin and the safety and efficacy of
daptomycin relative to comparator in the treatment of complicated skin and skin structure
infections in patients with renal impairment.